You are here

January 26, 2023
COVID-19, In the News

Update - Evusheld no longer authorized in the U.S.

POSTED BY:

January 26, 2023 - FDA revised its emergency use authorization (EUA) for Evusheld to limit its use to areas where more than 10% of circulating COVID-19 variants are known to be susceptible to it. Across the U.S., CDC data shows that such strains are less than 10% of those currently circulating, so Evusheld is not authorized until further notice.

Read More
January 25, 2023
Living with CGD

Son with chronic granulomatous disease goes through BMT with family’s support

POSTED BY:

Kathi and Rick Narlock have advocated for their son Nick Narlock since infancy when he was diagnosed with chronic granulomatous disease (CGD) and supported him as he underwent a bone marrow transplant (BMT) treatment.

Read More
January 24, 2023

IDF serves thousands through education, advocacy, and research efforts

POSTED BY:

In 2022, IDF’s programs and resources reached thousands of individuals in the primary immunodeficiency community and furthered advocacy and research goals.

Read More
January 19, 2023
Medicare

Medicare Home IVIG Benefit: FAQs

POSTED BY:

As the Medicare home IVIG demonstration project winds down with the new, permanent benefit starting January 1, 2024, here are answers to some frequently asked questions about the transition.

Read More
January 09, 2023
Education, Family, Peer Support, PI

Mom’s common variable immune deficiency diagnosis explains lifelong infections and fatigue

POSTED BY:

Susan Day’s diagnosis of common variable immune deficiency (CVID) at 41 helped explain the infections and fatigue she experienced since childhood and led to the testing of her children, who also have primary immunodeficiency (PI).

Read More